Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.
Press releases published on June 2, 2025

2025: New Launch of the Compliant Cloud Mining Platform Driving Next-Gen Tech and Market Leadership
Salford, Greater Manchester, England, June 02, 2025 (GLOBE NEWSWIRE) -- Global Cloud Mining proudly announces the rollout of its state-of-the-art Compliant Cloud Mining Platform, designed to set a new benchmark in cryptocurrency mining by fully aligning …

Under the Bitcoin Rally Wave, KixaMiner Unveils Your Journey to Efficient and Stable Passive Bitcoin Earnings
London, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency market ushers in another upsurge and Bitcoin prices hit new highs, KixaMiner, an innovator in the cloud mining sector, is building a fast track to digital asset wealth for …

ZA Miner Announces Strategic Investment to Revolutionize AI-Powered Cloud Mining with Global Green Expansion
London, UK, June 02, 2025 (GLOBE NEWSWIRE) -- ZA Miner, a trailblazer in cloud-based cryptocurrency mining, has officially announced a significant round of strategic investment aimed at scaling its cutting-edge AI-integrated mining infrastructure. This …

Luxren Capital Introduces a New Era in Mobile Trading: Secure, Regulated, and Always at Users' Fingertips
PORT LOUIS, MAURITIUS, June 02, 2025 (GLOBE NEWSWIRE) -- As more and more people across the world want flexible and fast-paced financial services, Luxren Capital is making a bold move by launching its innovative mobile trading platform. This platform is …

Century Applauds President Trump’s Aluminum Tariff Increase
CHICAGO, June 02, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) applauds President Trump’s unwavering defense of the nation’s domestic production of critical metals by increasing aluminum tariffs to 50 percent. President Trump’s action, …

IFEX Capital Introduces Its Latest Version of a Groundbreaking Trading Platform Connecting Traders Globally
PORT LOUIS, MAURITIUS, June 02, 2025 (GLOBE NEWSWIRE) -- IFEX Capital recently introduced a major leap forward in trading technology, setting new standards for reliability and lightning-fast execution with its recent platform updates. IFEX Capital's latest …

High Grade Ni/PGE Adjoining Globex’s Tyrone Property
ROUYN-NORANDA, Quebec, June 02, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …

Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma
TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy ORR is remarkably high in patients with no prior CAR-T or bispecific therapies (84%) as well as …

Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response (DDR) cancer therapies powered by artificial …

Robex Reports Operational and Financial Results for Q1 2025
QUÉBEC CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX/ASX: RXR) Matthew Wilcox, Managing Director, commented: "The company has had a strong start to 2025, construction continues to advance at Kiniero, and …

Fancamp Announces Appointment of CIO
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce the appointment of Mr. Kit Spring to the position of Chief Investment Officer (“CIO …

Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE …

Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML
Presentation at the International Conference on Malignant Lymphoma (ICML) in Lugano on June 21 SIDNEY is an ongoing Phase 2 trial of EO2463 in 48 indolent Non-Hodgkin Lymphoma (iNHL) patients Enterome has held a positive Type-C meeting with FDA for …

SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m Frequency – NEW YORK, June 02, 2025 (GLOBE …

Aventis Energy Announces Appointment of Michael Mulberry to the Board of Directors
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF), is pleased to announce that Mr. Michael Mulberry has been appointed to the board of directors of the …

PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
Median overall survival data in first-line recurrent/metastatic (1L r/m) HNSCC remains durable at 30.0 months with additional follow-up of ~4.5 months beyond the initial abstract HPV16-positive is the most rapidly increasing HNSCC in the US VERSATILE-003 …

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager Expect to share initial data in the first half of 2026 PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a …

BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will …

Amerigo Announces Board Appointment
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; ARREF:OTC) (“Amerigo” or the “Company”) is pleased to announce the appointment of Ignacio Cruz to the Company’s board of directors. Ignacio Cruz is a Civil …

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
WILMINGTON, Del., June 02, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June. …